Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 19 pp 8374—8385
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
Figure 7. Downregulation of lncRNA TTN-AS1 reduces drug resistance. (A, B) The effects of different concentrations of cisplatin on the viability of osteosarcoma cells are shown. (C, D) Downregulation of lncRNA TTN-AS1 enhanced the inhibitory effects of cisplatin on osteosarcoma cells. (E, F) Upregulation of lncRNA TTN-AS1 attenuated the inhibitory effect of cisplatin on osteosarcoma cells. *P < 0.05 vs. sh-NC and vector-NC group of 0 μM; #P < 0.05 vs. sh-NC and vector-NC group of 10 μM.